KORU Medical Systems Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2023

The following table summarizes the activities for our stock option plans for the six months ended June 30, 2023, and 2022.

Schedule of time based stock options

	June 30,
	2023		2022

Dividend yield		0.00%		0.00%
Expected Volatility		56.8% - 61.3%		65.9% - 77.5%
Weighted-average volatility		—		—
Expected dividends		—		—
Expected term (in years)		10		10
Risk-free rate		3.50% - 3.53%		1.81% - 2.99%

The following table summarizes the status of the time based stock options:

	Six Months Ended June 30,
	2023			2022
	Shares	Weighted Average Exercise Price		Shares		Weighted Average Exercise Price

Outstanding at January 1	3,035,000	$	3.92		3,672,500	$	3.42
Granted	85,000	$	3.94		770,000	$	2.68
Exercised	—	$	—		618,750	$	1.57
Forfeited	—	$	—		411,250	$	2.94
Outstanding at June 30	3,120,000	$	3.92		3,412,500	$	3.64
Options exercisable at June 30	1,158,750	$	4.37		837,500	$	3.47
Weighted average fair value of options granted during the period	—	$	2.78		—	$	2.03
Stock-based compensation expense	—	$	1,075,158		—	$	1,052,405

The following table presents information pertaining to options outstanding at June 30, 2023:

Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number Exercisable	Weighted Average Exercise Price

$2.25-$9.49	3,120,000	8.5 years	$	3.92	1,158,750	$	4.37

	Six Months Ended June 30,
	2023			2022
	Shares	Weighted Average Grant-Date Fair Value		Shares	Weighted Average Grant-Date Fair Value

Unvested at January 1	950,000	$	3.04	1,000,000	$	3.01
Granted	54,496	$	3.68	—	$	—
Vested	100,000	$	3.31	50,000	$	3.31
Forfeited/canceled	—	$	—	—	$	—
Unvested at June 30	904,496	$	2.97	950,000	$	2.99